Author: Kurian, Shilia Jacob; Unnikrishnan, Mazhuvancherry Kesavan; Miraj, Sonal Sekhar; Bagchi, Debasis; Banerjee, Mithu; Reddy, B Shrikar; Rodrigues, Gabriel Sunil; Manu, Mohan K; Saravu, Kavitha; Mukhopadhyay, Chiranjay; Rao, Mahadev
Title: Probiotics in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects Cord-id: 83aiu6yw Document date: 2021_3_19
ID: 83aiu6yw
Snippet: Saving lives and flattening the curve are the foremost priorities during the ongoing pandemic spread of SARS-CoV-2. Developing cutting-edge technology and collating available evidence would support frontline health teams. Nutritional adequacy improves general health and immunity to prevent and assuage infections. This review aims to outline the potential role of probiotics in fighting the COVID-19 by covering recent evidence on the association between microbiota, probiotics, and COVID-19, the ro
Document: Saving lives and flattening the curve are the foremost priorities during the ongoing pandemic spread of SARS-CoV-2. Developing cutting-edge technology and collating available evidence would support frontline health teams. Nutritional adequacy improves general health and immunity to prevent and assuage infections. This review aims to outline the potential role of probiotics in fighting the COVID-19 by covering recent evidence on the association between microbiota, probiotics, and COVID-19, the role of probiotics as an immune-modulator and antiviral agent. The high basic reproduction number (R0) of SARS-CoV-2, absence of conclusive remedies, and the pleiotropic effect of probiotics in fighting influenza and other coronaviruses together favour probiotics supplements. However, further support from preclinical and clinical studies and reviews outlining the role of probiotics in COVID-19 are critical. Results are awaited from many ongoing clinical trials investigating the benefits of probiotics in COVID-19.
Search related documents:
Co phrase search for related documents- activity lymphocyte and acute lung injury: 1
- activity lymphocyte and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9
- activity lymphocyte and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9
- activity lymphocyte and adaptive immune system: 1, 2, 3
- activity lymphocyte and adaptive immunity: 1, 2, 3
- activity lymphocyte and low density: 1
- activity lymphocyte and low density lipoprotein: 1
- activity lymphocyte and lung immunity: 1
- acute ards respiratory distress syndrome and adaptive immune system: 1, 2, 3, 4
- acute ards respiratory distress syndrome and adaptive immunity: 1, 2, 3, 4, 5, 6, 7
- acute ards respiratory distress syndrome and low density: 1, 2, 3, 4, 5, 6, 7
- acute ards respiratory distress syndrome and low density lipoprotein: 1
- acute ards respiratory distress syndrome and lung gut microbiota: 1, 2
- acute ards respiratory distress syndrome and lung immunity: 1, 2
- acute lung injury and adaptive immune system: 1, 2, 3
- acute lung injury and adaptive immunity: 1, 2, 3, 4, 5, 6
- acute lung injury and low density: 1, 2, 3
- acute lung injury and lung immunity: 1, 2, 3, 4, 5, 6, 7
- acute lung injury pathology and adaptive immunity: 1
Co phrase search for related documents, hyperlinks ordered by date